Ticker symbol

But then you have these six other AI labs that are called the Tigers.

Now, we call all of these the Tigers, but you have a company called Z.AI. And by the way, our product that tracks the model layer is the Tigers, TGRZ.

Right.

And the largest holding in it today is a company called Z.AI, which went public in Hong Kong.

20 months ago, a year and a half.

The time compression is very real.

So I'm curious, Kevin, with the new ETF you just released, China AI Tigers LLM ETF, ticker TGRZ.

And I'm curious how you think or how investors should think about the risks, right? I mean, what would you say would be the biggest risks to some of these, you know, sort of China AI model names? Is it the technological competition, which you've highlighted obviously very, very clearly? Is it the geopolitical risk? Is it the, you know, just exposure to China and the uncertainty that that could imply? Like, how do you think about the risk side of some of these, you know, emerging names?

Okay, the second stock is also old economy, and it's in the minerals area, and it is Nucor.

They own Nucor, ticker N-U-E-R. It's under Zach's Basic Materials, but it's a steel producer.

And you can't get more old school than steel, right? They actually describe themselves as a leading producer of structural steel, steel bars, steel joists, steel deck and cold finished bars in the US and Canada.

Now, one of the issues that struck me is they keep talking about how they're one of the biggest producers in North America.

And Emily, one of the names you're looking at actually was on the move in the after market.

Yeah, Oracle, ticker ORCL.

This is a company that has been down on the year quite a bit.

They were actually down 5% in the regular trading session, but they're now up over 6% in the post market.

For this category, we are tracking three specific tickers.

First, NVIDIA, ticker NVDA.

Mm.

Next, Broadcom, ticker AVGO, and Advanced Micro Devices, ticker AMD.

Good morning, Paul.

I'm looking at Amgen, ticker AMGN.

Shares are dropping as much as nine point two percent, and shares are on track for their worst day since November twenty twenty-four.

And this story really starts with Novartis.